Vertex Pharmaceuticals (VRTX) Depreciation & Amortization (CF) (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Depreciation & Amortization (CF) of $56.5 million for Q2 2026, up 1.07% on a QoQ basis from $55.9 million in Q1 2026, and up 9.28% year-over-year from $51.7 million in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported Depreciation & Amortization (CF) for 18 years, with the latest figure at $56.5 million in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 9.28% year-over-year to $56.5 million in Q2 2026; TTM through Jun 2026 was $222.1 million, a 11.16% increase from a year earlier, with the FY2025 full-year figure at $209.8 million, up 1.25% from the prior year.
- Depreciation & Amortization (CF) was $56.5 million for Q2 2026 at Vertex Pharmaceuticals, up from $55.9 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $59.0 million in Q4 2023, with the low at $35.9 million in Q1 2022.
- Average Depreciation & Amortization (CF) over 5 years is $47.7 million, with a median of $50.0 million recorded in 2025.
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) jumped 53.65% in 2023, then decreased 21.19% in 2024.
- Over 5 years, Depreciation & Amortization (CF) stood at $38.4 million in 2022, then surged by 53.65% to $59.0 million in 2023, then fell by 21.19% to $46.5 million in 2024, then gained by 19.78% to $55.7 million in 2025, then grew by 1.44% to $56.5 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $56.5 million (Q2 2026), $55.9 million (Q1 2026), and $55.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | - |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | 594.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 56.50 Mn |
| Mar 31, 2026 | 55.90 Mn |
| Dec 31, 2025 | 55.70 Mn |
| Sep 30, 2025 | 54.00 Mn |
| Jun 30, 2025 | 51.70 Mn |
| Mar 31, 2025 | 48.40 Mn |
| Dec 31, 2024 | 46.50 Mn |
| Sep 30, 2024 | 53.20 Mn |
| Jun 30, 2024 | 54.00 Mn |
| Mar 31, 2024 | 53.50 Mn |
| Dec 31, 2023 | 59.00 Mn |
| Sep 30, 2023 | 42.10 Mn |
| Jun 30, 2023 | 41.40 Mn |
| Mar 31, 2023 | 38.80 Mn |
| Dec 31, 2022 | 38.40 Mn |
| Sep 30, 2022 | 36.70 Mn |
| Jun 30, 2022 | 37.30 Mn |
| Mar 31, 2022 | 35.90 Mn |
| Dec 31, 2021 | 33.80 Mn |
| Sep 30, 2021 | 31.70 Mn |
API Access
Vertex Pharmaceuticals Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();